NO20040880L - Casein avledete peptider og anvendelser derav i terapi. - Google Patents

Casein avledete peptider og anvendelser derav i terapi.

Info

Publication number: NO20040880L
Authority: NO; Norway
Prior art keywords: casein; therapy; applications; derived peptides; peptides
Prior art date: 2001-08-30

Application number

NO20040880A

Other languages

English (en)

Norwegian (no)

Inventor

Zvi Sidelman

Original Assignee

Chay 13 Medical Res Group Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-30

Filing date

2004-02-27

Publication date

2004-04-20

2001-08-30 Priority claimed from US09/942,121 external-priority patent/US20020147144A1/en

2004-02-27 Application filed by Chay 13 Medical Res Group Nv filed Critical Chay 13 Medical Res Group Nv

2004-04-20 Publication of NO20040880L publication Critical patent/NO20040880L/no

Links

239000005018 casein Substances 0.000 title 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 title 1
235000021240 caseins Nutrition 0.000 title 1
102000004196 processed proteins & peptides Human genes 0.000 title 1
108090000765 processed proteins & peptides Proteins 0.000 title 1
238000002560 therapeutic procedure Methods 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Diabetes (AREA)
Hematology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oncology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Zoology (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Toxicology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Marine Sciences & Fisheries (AREA)
AIDS & HIV (AREA)
Emergency Medicine (AREA)
Tropical Medicine & Parasitology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

NO20040880A 2001-08-30 2004-02-27 Casein avledete peptider og anvendelser derav i terapi. NO20040880L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/942,121 US20020147144A1 (en)	2000-03-01	2001-08-30	Casein derived peptides and uses thereof in therapy
PCT/IL2002/000720 WO2003018606A2 (en)	2001-08-30	2002-08-29	Casein derived peptides and uses thereof in therapy

Publications (1)

Publication Number	Publication Date
NO20040880L true NO20040880L (no)	2004-04-20

Family

ID=25477603

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20040880A NO20040880L (no)	2001-08-30	2004-02-27	Casein avledete peptider og anvendelser derav i terapi.

Country Status (15)

Country	Link
EP (1)	EP1556074A4 (de)
JP (1)	JP2005511499A (de)
KR (1)	KR20040078639A (de)
CN (1)	CN1694719A (de)
AU (1)	AU2002324323A2 (de)
BR (1)	BR0212625A (de)
CA (1)	CA2458924A1 (de)
CZ (1)	CZ2004335A3 (de)
HU (1)	HUP0500995A3 (de)
IL (1)	IL160548A0 (de)
MX (1)	MXPA04001890A (de)
NO (1)	NO20040880L (de)
PL (1)	PL375113A1 (de)
WO (1)	WO2003018606A2 (de)
ZA (1)	ZA200401574B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0313892D0 (en) *	2003-06-16	2003-07-23	Hannah Res Inst	Control of lactation
WO2005074599A2 (en) *	2004-01-30	2005-08-18	Chemgenex Pharmaceuticals, Inc.	Naphthalimide dosing by n-acetyl transferase genotyping
WO2005081628A2 (en) *	2004-03-01	2005-09-09	Peptera Pharmaceutical Ltd.	Casein derived peptides and therapeutic uses thereof
GB0423352D0 (en) *	2004-10-21	2004-11-24	Hannah Res Inst	"Control of mammary cell number"
ES2319475B1 (es) *	2005-06-08	2010-02-16	Consejo Superior Investig. Cientificas	Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion.
CN101410131B (zh)	2006-06-09	2012-09-12	森永乳业株式会社	脂质代谢改善剂
JP2011026213A (ja) *	2009-07-22	2011-02-10	Snow Brand Milk Prod Co Ltd	１型糖尿病抑制ペプチド
EP2839291B1 (de) *	2012-04-16	2018-07-04	The Cleveland Clinic Foundation	Multivalenter brustkrebsimpfstoff
CN110381964A (zh) *	2017-03-03	2019-10-25	森永乳业株式会社	Glp-1分泌促进剂和组合物
CN107814835B (zh) *	2017-12-01	2020-04-28	熊猫乳品集团股份有限公司	一种生物活性多肽avpitptlnreq及其制备方法和应用
CN108017709B (zh) *	2017-12-12	2020-04-10	浙江辉肽生命健康科技有限公司	一种生物活性多肽kepmigvnqela及其制备方法和应用
CN113952446B (zh) *	2021-09-03	2023-12-05	河南省医药科学研究院	生物活性肽在抑制骨髓毒性中的应用
CN120815163B (zh) *	2025-09-16	2025-12-12	华中科技大学同济医学院附属同济医院	能抑制ccnb2表达的抗肿瘤药物和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3778426A (en) *	1970-12-16	1973-12-11	Research Corp	Therapeutically useful polypeptides
AU729978B2 (en) *	1997-03-21	2001-02-22	Snow Brand Milk Products Co., Ltd.	Iron-partial hydrolyzates of casein complexes and processes for preparation thereof
IL134830A0 (en) *	2000-03-01	2001-05-20	Chay 13 Medical Res Group N V	Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them

2002
- 2002-08-29 BR BRPI0212625-7A patent/BR0212625A/pt not_active IP Right Cessation
- 2002-08-29 PL PL02375113A patent/PL375113A1/xx not_active Application Discontinuation
- 2002-08-29 WO PCT/IL2002/000720 patent/WO2003018606A2/en not_active Ceased
- 2002-08-29 EP EP02758768A patent/EP1556074A4/de not_active Withdrawn
- 2002-08-29 CN CNA028216741A patent/CN1694719A/zh active Pending
- 2002-08-29 KR KR10-2004-7002884A patent/KR20040078639A/ko not_active Withdrawn
- 2002-08-29 HU HU0500995A patent/HUP0500995A3/hu unknown
- 2002-08-29 MX MXPA04001890A patent/MXPA04001890A/es not_active Application Discontinuation
- 2002-08-29 JP JP2003523265A patent/JP2005511499A/ja active Pending
- 2002-08-29 CA CA002458924A patent/CA2458924A1/en not_active Abandoned
- 2002-08-29 CZ CZ2004335A patent/CZ2004335A3/cs unknown
- 2002-08-29 IL IL16054802A patent/IL160548A0/xx unknown
- 2002-08-29 AU AU2002324323A patent/AU2002324323A2/en not_active Abandoned
2004
- 2004-02-26 ZA ZA200401574A patent/ZA200401574B/en unknown
- 2004-02-27 NO NO20040880A patent/NO20040880L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CN1694719A (zh)	2005-11-09
HUP0500995A3 (en)	2008-09-29
JP2005511499A (ja)	2005-04-28
WO2003018606A9 (en)	2004-04-08
HUP0500995A2 (en)	2007-05-02
AU2002324323A2 (en)	2003-03-10
PL375113A1 (en)	2005-11-28
EP1556074A2 (de)	2005-07-27
EP1556074A4 (de)	2008-05-07
WO2003018606A2 (en)	2003-03-06
CA2458924A1 (en)	2003-03-06
ZA200401574B (en)	2007-02-28
WO2003018606A3 (en)	2005-05-06
KR20040078639A (ko)	2004-09-10
CZ2004335A3 (cs)	2004-07-14
IL160548A0 (en)	2004-07-25
MXPA04001890A (es)	2004-06-18
BR0212625A (pt)	2007-06-19

Legal Events

Date	Code	Title	Description
2009-03-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
DK1641822T3 (da)	2013-07-22	Heterologe il-17-a/f-polypeptider og terapeutiske anvendelser deraf.
HUP0301003A3 (en)	2007-08-28	Casein derived peptides and uses thereof in therapy
DK1390389T3 (da)	2009-04-20	Cripto-blokerende antistoffer og anvendelser deraf
DK1680443T3 (da)	2013-12-16	Stabiliserede alfa-helix-peptider og anvendelser heraf
EP1461605A4 (de)	2009-10-21	Protein- und peptid-nanoarrays
NO20034962D0 (no)	2003-11-07	Beta-amyloid peptid-bindende proteiner og polynukleotider som koder for samme
NO20040880L (no)	2004-04-20	Casein avledete peptider og anvendelser derav i terapi.
DK1462455T3 (da)	2013-07-01	Ser-Ser-Ser-Arg-peptid samt medicinske anvendelser deraf
NO20020919L (no)	2002-04-25	Irenprotein, dets fremstilling og anvendelse
NO20005547L (no)	2001-01-02	Myelinbasisproteinpeptider og anvendelser derav
EP1389126A4 (de)	2006-06-28	Retrocycline: antivirale und antimikrobielle peptide
NO20012030L (no)	2002-10-28	Kryptografisk signering i små enheter
PT1140803E (pt)	2004-03-31	(aminoiminometil)amino)alcanocarboxamidas e suas aplicacoes em terapia
EP1383907A4 (de)	2005-06-15	Isolierte menschliche protease-proteine, menschliche protease-proteine codierende nukleinsäuremoleküle sowie verwendungen davon
CY1105287T1 (el)	2010-03-03	Ορχεως - ειδικη ανθρωπινη svph1-8 πρωτεϊναση
EP1379678A4 (de)	2005-04-13	Isolierte menschliche proteaseproteine, menschliche proteaseproteine codierende nukleinsäuremoleküle und verwendungen davon
EP1395674A4 (de)	2005-04-20	Isolierte menschliche proteaseproteine, menschliche proteaseproteine codierende nukleinsäuremoleküle und verwendungen davon
DE10045123B8 (de)	2008-01-24	Das C. albicans TEC1 GEN(CaTEC1) und das kodierte Tec1p Protein
DK1897945T3 (da)	2012-05-07	IL-17 homologe polypeptider og terapeutiske anvendelser deraf.
AU8557801A (en)	2002-03-13	Modified proteins, isolated novel peptides, and uses thereof
NO20024029L (no)	2002-10-24	Nytt protein og gen som koder for proteinet
AU8748101A (en)	2001-12-24	A novel polypeptide, a human protein stat2 and the polynucleotide encoding the polypeptide
AU2003303464A8 (en)	2004-07-22	Centrosome-associated protein and applications thereof
AU2003227428A8 (en)	2003-11-03	Novel proteins and dnas encoding the same
AU2003235099A8 (en)	2003-11-10	Novel proteins and dnas encoding the same